A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)
Clinical trial NCT02706951 · COMPLETED
Trial details
- NCT number
- NCT02706951
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2017-10-02
- Enrollment
- 648
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.